Cancer of unknown primary site: 20 questions to be answered.
暂无分享,去创建一个
[1] N. Pavlidis,et al. Switching benchmarks in cancer of unknown primary: from autopsy to microarray. , 2007, European journal of cancer.
[2] N. Pavlidis,et al. Carcinoma of Unknown Primary (CUP) , 2014 .
[3] J. Hainsworth,et al. Neuroendocrine carcinoma of unknown primary site. , 2009, Seminars in oncology.
[4] J. Verweij,et al. Carcinoma of unknown primary: identification of a treatable subset? , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] K. Oien,et al. Pathologic evaluation of unknown primary cancer. , 2009, Seminars in oncology.
[6] M. Erlander,et al. Molecular classification of unknown primary cancer. , 2009, Seminars in oncology.
[7] M. Kodaira,et al. Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] E. Felip,et al. Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] N. Pavlidis,et al. Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: Active, but how effective? , 2005, Acta oncologica.
[10] M. Burgess,et al. Prognostic factors in metastatic carcinoma of unknown primary. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] C. Muir,et al. International Classification of Diseases for Oncology , 1990 .
[12] J. Hainsworth,et al. Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] G. Varadhachary,et al. Carcinoma of Unknown Primary , 2001 .
[14] J. Hainsworth,et al. Diagnostic and therapeutic management of cancer of an unknown primary. , 2003, European journal of cancer.
[15] N. Pavlidis,et al. Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence , 2009, Breast Cancer Research and Treatment.
[16] N. Pavlidis,et al. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[17] N. Pavlidis,et al. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature. , 2008, Cancer treatment reviews.
[18] N. Pavlidis,et al. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review. , 2009, Cancer treatment reviews.
[19] J. Hainsworth,et al. Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. , 1986, Annals of internal medicine.
[20] J. Hainsworth,et al. Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. , 2009, The oncologist.
[21] J. Ioannidis,et al. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. , 2009, Cancer treatment reviews.
[22] K. Hess,et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] N. Pavlidis,et al. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. , 2010, Critical reviews in oncology/hematology.